BRTX icon

BioRestorative Therapies
BRTX

11 hedge funds and large institutions have $184K invested in BioRestorative Therapies in 2026 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $
Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$134K
2
+$106K
3
+$64.1K
4
TRCT
Tower Research Capital (TRC)
New York
+$229
5
SS
SBI Securities
Japan
+$51

Top Sellers

1
-$54.8K
2
-$20.1K
3
-$13.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$64.9K
Geode Capital Management
2
Geode Capital Management
Massachusetts
$60.7K
UBS Group
3
UBS Group
Switzerland
$27.2K
WA
4
Wealth Alliance
New York
$10.9K
VFT
5
Vanguard Fiduciary Trust
Pennsylvania
$10.7K
State Street
6
State Street
Massachusetts
$8.83K
Osaic Holdings
7
Osaic Holdings
Arizona
$540
TRCT
8
Tower Research Capital (TRC)
New York
$398
SS
9
SBI Securities
Japan
$54
TWC
10
TD Waterhouse Canada
Ontario, Canada
$1
DS
11
DRW Securities
Illinois
–
NF
12
Napier Financial
Massachusetts
–
TSS
13
Two Sigma Securities
New York
–
CIAM
14
Caitong International Asset Management
Hong Kong
–